PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Enzymes implicated in disease processes attack one another instead of harming body proteins

Cathepsin cannibalism

Enzymes implicated in disease processes attack one another instead of harming body proteins
2012-08-13
(Press-News.org) Researchers for the first time have shown that members of a family of enzymes known as cathepsins – which are implicated in many disease processes – may attack one another instead of the bodily proteins they normally degrade. Dubbed "cathepsin cannibalism," the phenomenon may help explain problems with drugs that have been developed to inhibit the effects of these powerful proteases.

Cathepsins are involved in disease processes as varied as cancer metastasis, atherosclerosis, cardiovascular disease, osteoporosis and arthritis. Because cathepsins have harmful effects on critical proteins such as collagen and elastin, pharmaceutical companies have been developing drugs to inhibit activity of the enzymes, but so far these compounds have had too many side effects to be useful and have failed clinical trials.

Using a combination of modeling and experiments, researchers from the Georgia Institute of Technology and Emory University have shown that one type of cathepsin preferentially attacks another, reducing the enzyme's degradation of collagen. The work could affect not only the development of drugs to inhibit cathepsin activity, but could also lead to a better understanding of how the enzymes work together.

"These findings provide a new way of thinking about how these proteases are working with and against each other to remodel tissue – or fight against each other," said Manu Platt, an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. "There has been an assumption that these cathepsins have been inert in relationship to one another, when in actuality they have been attacking one another. We think this may have broader implications for other classes of proteases."

The research was supported by the National Institutes of Health, the National Science Foundation and the Georgia Cancer Coalition. Details of the study were reported August 10 in the Journal of Biological Chemistry.

Platt and student Zachary Barry made their discovery accidentally while investigating the effects of cathepsin K and cathepsin S – two of the 11-member cathepsin family. Cathepsin K degrades both collagen and elastin, and is one of the most powerful proteases. Cathepsin S degrades elastin, and does not strongly attack collagen.

When the researchers combined the two cathepsins and allowed them to attack samples of elastin, they expected to see increased degradation of the protein. What they saw, however, was not much more damage than cathepsin K did by itself.

Platt at first believed the experiment was flawed, and asked Barry – an undergraduate student in his lab who specializes in modeling – to examine what possible conditions could account for the experimental result. Barry's modeling suggested that effects observed could occur if cathepsin S were degrading cathepsin K instead of attacking the elastin – a protein essential in arteries and the cardiovascular system.

That theoretical result led to additional experiments in which the researchers measured a direct correlation between an increase in the amount of cathepsin S added to the experiment and a reduction in the degradation of collagen. By increasing the amount of cathepsin S ten-fold over the amount used in the original experiment, Platt and Barry were able to completely block the activity of cathepsin K, preventing damage to the collagen sample.

"We saw that the cathepsin K was going away much faster when there was cathepsin S present than when it was by itself," said Platt, who is also a Georgia Cancer Coalition Distinguished Scholar and a Fellow of the Keystone Symposia on Molecular and Cellular Biology. "We kept increasing the amount of cathepsin S until the collagen was not affected at all because all of the cathepsin K was eaten by the cathepsin S."

The researchers used a variety of tests to determine the amount of each enzyme, including fluorogenic substrate analysis, Western blotting and multiplex cathepsin zymography – a sensitive technique developed in the Platt laboratory.

Beyond demonstrating for the first time that cathepsins can attack one another, the research also shows the complexity of the body's enzyme system – and may suggest why drugs designed to inhibit cathepsins haven't worked as intended.

"The effect of the cathepsins on one another complicates the system," said Platt. "If you are targeting this system pharmaceutically, you may not have the types or quantities of cathepsins that you expect, which could cause off-target binding and side effects that were not anticipated."

Platt's long-term research has focused on cathepsins, including the development of sensitive tools and assays to quantify their activity in cells and tissue, as well as potential diagnostic applications for breast, lung and cervical cancer. Cathepsins normally operate within cells to carry out housekeeping tasks such as breaking down proteins that are no longer needed.

"These enzymes are very powerful, but they have been overlooked because they are difficult to study," said Platt. "We are changing the way that people view them."

For the future, Platt plans to study interactions of additional cathepsins – as many as three or four are released during certain disease processes – and to develop a comprehensive model of how these proteases interact while they degrade collagen and elastin. That model could be useful to the designers of future drugs.

"As we build toward a comprehensive model of how these enzymes work, we can begin to understand how they behave in the extracellular matrix around these cells," said Platt. "That will help us be smarter about how we go about treating diseases and designing new drugs."



INFORMATION:

The project described was supported by Award Number DP2OD007433 from the Office of the Director, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Office of the Director, National Institutes of Health, or the National lnstitutes of Health. This material is also based on work supported by the National Science Foundation under the Science and Technology Center Emergent Behaviors of Integrated Cellular systems (EBICS) Grant No. CBET-0939511.


[Attachments] See images for this press release:
Enzymes implicated in disease processes attack one another instead of harming body proteins

ELSE PRESS RELEASES FROM THIS DATE:

New class of proteins allows breast cancer cells to evade tyrosine kinase inhibitors

2012-08-13
Aberrant regulation of cell growth pathways is required for normal cells to become cancerous, and in many types of cancer, cell growth is driven by a group of enzymes known as receptor tyrosine kinases (RTKs). The RTK epidermal growth factor receptor (EGFR) is overexpressed in over 30% of breast cancers; however, drugs that target RTKs, known as tyrosine kinase inhibitors (TKIs) have not been effective in treating breast cancer. Researchers believe that the cancer cells escape TKIs by circumventing the RTKs and utilizing other enzymes that are not TKI-sensitive. In the ...

Common antibiotics pose a rare risk of severe liver injury in older patients

2012-08-13
Please credit CMAJ, not the Canadian Medical Association. CMAJ is an independent medical journal; views expressed here do not necessarily reflect those of its owner, the CMA. END ...

Protein that helps tumor blood vessels mature could make cancer drugs more effective

Protein that helps tumor blood vessels mature could make cancer drugs more effective
2012-08-13
ORLANDO, Fla., August 13, 2012 – To survive, tumors need blood supply to provide them with nutrients and oxygen. To get that supply, cancer cells stimulate new blood vessel growth—a process called tumor angiogenesis. Many attempts have been made to inhibit this process as a means to choke off tumors. But tumor angiogenesis can be sloppy, resulting in immature and malformed blood vessels. Since anti-cancer drugs are carried to tumors by the bloodstream, abnormal blood vessel development also hampers delivery. What if, rather than putting a stop to angiogenesis, we could ...

Journal of Clinical Investigation early table of contents for Aug. 13, 2012

2012-08-13
New class of proteins allows breast cancer cells to evade Tyrosine Kinase Inhibitors Aberrant regulation of cell growth pathways is required for normal cells to become cancerous, and in many types of cancer, cell growth is driven by a group of enzymes known as receptor tyrosine kinases (RTKs). The RTK epidermal growth factor receptor (EGFR) is overexpressed in over 30% of breast cancers; however, drugs that target RTKs, known as tyrosine kinase inhibitors (TKIs) have not been effective in treating breast cancer. Researchers believe that the cancer cells escape TKIs by ...

CNIO researchers discover a new therapy that prevents lung cancer growth in mice

2012-08-13
Lung cancer is one of the most aggressive types of cancer and the most common cause of death from this disease worldwide. Despite the progress in the molecular biology of lung cancer achieved in recent years, the mechanisms used by tumor cells to grow and spread throughout the body are not yet completely understood. This lack of information is responsible for the limited range of available therapeutic possibilities and their undesirable side effects. The Tumour Suppression Group of the Spanish National Cancer Research Centre (CNIO), led by Manuel Serrano, has deciphered ...

Fruity science halves fat in chocolate

2012-08-13
Scientists have found a way to replace up to 50 per cent of chocolate's fat content with fruit juice. University of Warwick chemists have taken out much of the cocoa butter and milk fats that go into chocolate bars, substituting them with tiny droplets of juice measuring under 30 microns in diameter. They infused orange and cranberry juice into milk, dark and white chocolate using what is known as a Pickering emulsion. Crucially, the clever chemistry does not take away the chocolatey 'mouth-feel' given by the fatty ingredients. This is because the new technique maintains ...

New bacteria-resistant materials discovered

New bacteria-resistant materials discovered
2012-08-13
Using state-of-the-art technology scientists at The University of Nottingham have discovered a new class of polymers that are resistant to bacterial attachment. These new materials could lead to a significant reduction in hospital infections and medical device failures. Medical device associated infections can lead to systemic infections or device failure, costing the NHS £1bn a year. Affecting many commonly used devices including urinary and venous catheters — bacteria form communities known as biofilms. This 'strength in numbers approach' protects them against the bodies' ...

The ins and outs of building the sperm tail

The ins and outs of building the sperm tail
2012-08-13
Sperm swim, lung cells sweep mucus away, and the cells in the female Fallopian tube move eggs from the ovary to the uterus. Underlying these phenomena are flagella – slender, hair-like structures extending from the surface of the cells, that bend, beat or wave rhythmically. In the latest issue of the journal Developmental Cell*, scientists from the Instituto Gulbenkian de Ciência (IGC), in Portugal, have dissected how sperm cells of the fruit fly build their flagella. These findings pave the way to further understand the molecules and processes that may trigger a variety ...

NTU scientist invents pocket living room TV

2012-08-13
Leaving your TV show midway because you had to leave your home will no longer happen as you can now 'pull' the programme on your TV screen onto your tablet and continue watching it seamlessly. You can also watch the same TV show or movie together with your family and friends, no matter which part of the world they are in. Not only that but you'll be able to discuss the show, whether you are on your personal tablet or smart phone, through a channel of your choice, be it video chat, voice or text. The world's first 'pick up and throw back' video feature allows your video ...

Smoking increases, while alcohol consumption may decrease risk of ALS

2012-08-13
A population-based case-control study of the rare but devastating neurological disease amyotrophic lateral sclerosis (ALS) has shown that the risk of such disease is increased among smokers, as has been shown previously. However, surprisingly, the risk of ALS was found to be markedly lower among consumers of alcohol than among abstainers. Forum reviewers thought that this was a well-done and important paper, as it is a population-based analysis, with almost 500 cases of ALS, a very large number of cases for this rare disease. They were especially struck by the magnitude ...

LAST 30 PRESS RELEASES:

Nearly half of adults mistakenly think benefits of daily aspirin outweigh risks

Cardiovascular disease medications underused globally

Amazon Pharmacy's RxPass program improves medication adherence, helps prime members save money, study finds

Tufts University School of Medicine, ATI Physical Therapy launch first-of-its-kind collaboration to make physical therapy education and career advancement more accessible and affordable

Could lycopene—a plant extract—be an effective antidepressant?

Study shows urine test for prostate cancer could be used at home

Shaping future of displays: clay/europium-based technology offers dual-mode versatility

Optimizing ADHD treatment: revealing key components of cognitive–behavioral therapy

Breaking barriers in thioxanthone synthesis: a double aryne insertion strategy

Houston Methodist researchers identify inhibitor drugs to treat aggressive breast cancer

Skin disease patients show response to targeted treatment

Tiny copper ‘flowers’ bloom on artificial leaves for clean fuel production

Cracks in Greenland Ice Sheet grow more rapidly in response to climate change

Computer model helps identify cancer-fighting immune cells key to immunotherapy

Keeper or corner?

Printable molecule-selective nanoparticles enable mass production of wearable biosensors

Mapping the yerba mate genome reveals surprising facts about the evolution of caffeine

Electricity prices across Europe to stabilise if 2030 targets for renewable energy are met, study suggests

Improved treatment timing reduces honey bee losses to Varroa mites

CAR-T cells can arm bystander T cells with CAR molecules via trogocytosis

Can ocean-floor mining oversights help us regulate space debris and mining on the Moon?

Observing ozonated water’s effectiveness against SARS-CoV-2 in saliva

Alcohol-related deaths up 18% during pandemic

Mothers of twins face a higher risk of heart disease in the year after birth

A new approach to detecting Alzheimer’s disease

Could the contraceptive pill reduce risk of ovarian cancer?

Launch of the most comprehensive, and up to date European Wetland Map

Lurie Children’s campaign urges parents to follow up right away if newborn screening results are abnormal

Does drinking alcohol really take away the blues? It's not what you think

Speed of risk perception is connected to how information is arranged

[Press-News.org] Enzymes implicated in disease processes attack one another instead of harming body proteins
Cathepsin cannibalism